Zomedica Corp. (ZOM)
Zomedica Statistics
Share Statistics
Zomedica has 979.95M shares outstanding. The number of shares has increased by 0% in one year.
| 979.95M |
| 0% |
| 0% |
| 30.72% |
| 961.65M |
| 10,014 |
| 0.12% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -5.68 and the forward PE ratio is null. Zomedica's PEG ratio is -0.06.
| -5.68 |
| n/a |
| 7.79 |
| 1.6 |
| 0.82 |
| -9.51 |
| -0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Zomedica.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 11.06, with a Debt / Equity ratio of 0.01.
| 11.06 |
| 10.49 |
| 0.01 |
| -0.09 |
| -0.13 |
| -180.53 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $174,902.78 |
| $-239,784.72 |
| 144 |
| 0.1 |
| 1.54 |
Taxes
| -1.33M |
| 3.71% |
Stock Price Statistics
The stock price has increased by -23.2% in the last 52 weeks. The beta is 1.16, so Zomedica's price volatility has been higher than the market average.
| 1.16 |
| -23.2% |
| 0.09 |
| 0.12 |
| 41.48 |
| 8,541,418 |
Income Statement
In the last 12 months, Zomedica had revenue of 25.19M and earned -34.53M in profits. Earnings per share was -0.04.
| 25.19M |
| 17.32M |
| -31.59M |
| -34.53M |
| -29.39M |
| -35.69M |
| -0.04 |
Balance Sheet
The company has 12.95M in cash and 2.73M in debt, giving a net cash position of 10.22M.
| 12.95M |
| 2.73M |
| 10.22M |
| -170.93M |
| 214.12M |
| 79.21M |
Cash Flow
In the last 12 months, operating cash flow was -15.97M and capital expenditures -4.65M, giving a free cash flow of -20.62M.
| -15.97M |
| -4.65M |
| -20.62M |
| -0.02 |
Margins
Gross margin is 68.76%, with operating and profit margins of -125.43% and -137.1%.
| 68.76% |
| -125.43% |
| -142.38% |
| -137.1% |
| -116.68% |
| -125.43% |
| -81.87% |
Dividends & Yields
ZOM does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 3.31 |
| 3 |